Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …

Background Astragalus-containing traditional Chinese medicine (TCM) is widely used as
adjunctive treatment to platinum-based chemotherapy (PBC) in patients with advanced …

Background Chemotherapy is the standard treatment for small cell lung cancer (SCLC), but
chemotherapy resistance and adverse reactions remain major problems. Although …

Background: Many studies were performed to explore the correlation between taxane-based
chemotherapy and the risk of breast cancer-related lymphedema (BCRL), however, with …

Immune microenvironment and immunotherapy have become the focus and frontier of tumor
research, and the immune checkpoint inhibitors has provided novel strategies for tumor …

Background: Increasing studies were performed to explore the prognostic value of E-
cadherin in prostatic carcinoma, however, with inconsistent results. Hence, this systematic …

Background: Traditional Chinese Medicine (TCM) therapies have been combined with
chemotherapy for preventing Recurrence and metastasis in postoperative II to IIIA non-small …

Objective P-cadherin can act both as a tumour suppressor and an oncogene. The clinical
prognostic value of P-cadherin overexpression in breast cancer (BC) remains unclear. We …

Ethnopharmacological relevance Xiaoshui decoction (XSD) is a traditional Chinese
medicine compound prescription that has been shown to reinforce the spleen and remove …

Introduction: Pancreatic cancer is one of the most lethal malignancies worldwide. Most
patients are diagnosed at an advanced stage, which leads to a poor prognosis and a low …